Skip Navigation
 

Southeastern Kidney Disease Consortium

POSEIDON Study

Prevention, Optimizing Safety, Early Intervention and DetectiOn in Nephrology (POSEIDON)

Tell me more about the POSEIDON Study...  

POSEIDON Study - What is it?

This research study is sponsored by MUSC and the goal is to develop a registry and sample bank called Poseidon (Prevention, Optimizing Safety, Early Intervention and DetectiOn in Nephrology) biobank. Samples collected in this study may be used for future research. The future research has not yet been determined but it could include studies that would help identify better treatment and diagnostic options for patients with kidney disease.  Also, in the future, the study may be expanded to include private clinics outside of MUSC for which an IRB amendment will be submitted by the Principal Investigator.

POSEIDON Study - Who can participate?

Any patient can participate, you do not have be diagnosed with Chronic Kindey Disease. Patients are asked to volunteer for this research study during their routine clinical visit.  The purpose of this study is to collect and store bodily materials in order to help researchers develop a larger clinical storage bank. The patient is asked to participate in this study because they  have bodily materials that are already being collected as a part of their routine care.  Patients donating materials will not affect the use of their materials for routine diagnosing or medical treatment purposes.  The patient's samples may be used by other investigators for future research. The investigator in charge of this study is Dr. John Arthur.  The study is being done at MUSC and will involve approximately 2500 volunteers.

POSEIDON Study - Why is it important?

Biomedical research is frequently slowed by the inability to obtain specimens from patients with relevant diseases and appropriate clinical data. Kidney disease affects up to 20% of the US population and is a strong contributor to morbidity and mortality in these patients. Specific therapies and diagnostic tools for kidney disease have been very slow to develop because of the absence of high quality samples and data that can be used for research studies. The current proposal outlines procedures for individual consent of patients to allow them to have their data collected for a registry and samples taken and deposited in the Poseidon biobank. In this study proposal, patients can consent to donating their residual kidney tissue if they undergo a kidney biopsy and blood or urine during routine clinical care procedures. There will be no expiration date for the length of time samples will be stored in the Poseidon biobank.

WHAT IS CHRONIC KIDNEY DISEASE?    
Chronic Kidney Disease (CKD) reduces the body’s ability to filter blood, remove waste and extra water, and keep beneficial electrolytes in balance.
KIDNEY DISEASE IN SC
  • 1 in 8 South Carolinians have Chronic Kidney Disease (CKD). 
  • Approximately 576,000 people have CKD in South Carolina. 
  • South Carolina is, per capita, fifth in the nation with the number of patients on dialysis. 
  • 75% of kidney patients in South Carolina are African American. 
  • Three out of four of those waiting for a kidney are African American, and South Carolina ranks second in the nation in the need for organs among African Americans.

For more information regarding Chronic Kidney Disease published by DHEC (2012), click on the link. * Note in order to view these documents you will need to have the free Adobe Reader® installed on your computer.  More on Adobe Acrobat®.
* Note in order to view these documents you will need to have the free Adobe Reader® installed on your computer.  More on Adobe Acrobat®.
SEKDC and POSEIDON Research  Partners
POSEIDON Investigator: 
Dr. Pusadee Suchinda, Nephrology, Internal Medicine
Dr. Usah Lilavivat, F.A.C.P., F.A.C.E., President
    
POSEIDON Site Coordinator:
Kim Bocchicchia, Clinical Coordinator
Member Since:   February 7, 2013

POSEIDON Study Contact Information:

John Arthur, MD, PhD
DCI Endowed Chair in Nephrology
Professor
Director of the SC Renal Disease Biomarkers Program,
      Proteomics Laboratory and SEKDC
Divsion of Nephrology
829 CSB, MUSC
96 Jonathon Lucas St
Charleston, SC 29425
Elizabeth Shewfelt, MS, MA
Study Coordinator
Program Coordinator
RDB Newsletter Creator/Editor
Divison of Nephrology
829 CSB, MUSC
96 Jonathon Lucas St
Charleston, SC 29425
Phone: 843-792-4123 
Fax: 843-876-5129                                        
e-mail: arthurj@musc.edu
Phone: 843-792-6109 (Direct Line)
Fax: 843-876-5129
e-mail: shewfelt@musc.edu

                                                                                                      

                                                                                                                                                           

 
 
 

© 2012  Medical University of South Carolina | Disclaimer